Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2008
Total Assets: $111.15B
Liabilities Breakdown FY2008
Total Liabilities: $53.41B
Asset Breakdown
Total Assets: $111.15B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.12B | 1.9% |
| Accounts Receivable | $8.96B | 8.1% |
| Inventory | $4.38B | 3.9% |
| Property, Plant & Equipment | $13.29B | 12.0% |
| Goodwill | $21.46B | 19.3% |
| Intangible Assets | $17.72B | 15.9% |
| Other Assets | $43.22B | 38.9% |
Liabilities Breakdown
Total Liabilities: $53.41B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.75B | 3.3% |
| Long-Term Debt | $7.96B | 14.9% |
| Other Liabilities | $43.69B | 81.8% |